Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study)

Lars Lund1 Department of Urology, Odense University Hospital, [email protected];2 Clinical Institute, Southern University of Denmark, Odense, Denmark, [email protected]Correspondence[email protected]

Harry Nisen3 Department of Urology, Helsinki University Hospital, Helsinki, Finland

Petrus Järvinen3 Department of Urology, Helsinki University Hospital, Helsinki, Finland

Magnus Fovaeus4 Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden

Eirikur Gudmundsson5 Department of Urology, Landspitali University Hospital, Reykjavik, Iceland

Bjarne Kromann-Andersen6 Department of Urology, Herlev University Hospital, Copenhagen, Denmark

Börje Ljungberg7 Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden

Frode Nilsen8 Department of Urology, Akershus University Hospital, Lörenskog, Norway

Pernilla Sundqvist9 Department of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

Peter E Clark10 Department of Urology, Atrium Health, Charlotte, NC, USA

Christian Beisland11 Department of Urology, Haukeland University Hospital;12 Department of Clinical Medicine, University of Bergen, Bergen, Norway

Your download is now in progress and you may close this window